m-RNA 合成服務市場：按應用、運營規模、最終用戶（生物製藥公司、CRO、其他）、地區 - 規模、份額、前景、機會分析，2023-2030 年

轉錄是以 DNA 為模板合成信使 RNA (mRNA)。 mRNA 將遺傳信息從細胞核中的染色體 DNA 攜帶到細胞質表面。 mRNA 是用於基因編輯、細胞治療、疫苗接種和治療性蛋白質替代的靈活工具。 由於可以通過 mRNA 引入任何蛋白質，因此可以在細胞內產生基因編輯工具和抗原。

mRNA 是一種單鏈 RNA 分子，與基因的一條 DNA 鏈互補。 合成 mRNA 用於研究蛋白質介導的 mRNA 識別、mRNA 輸出和翻譯、突變對蛋白質編碼基因的影響等。 近年來，開發了使用mRNA的藥物用於治療各種疾病，例如呼吸系統疾病、心髒病、代謝疾病、自身免疫性疾病、癌症、癌症免疫療法和疫苗接種。

市場動態

預計市場參與者之間收購的增加將推動預測期內的市場增長。 例如，2022 年 1 月，為研究人員和生物技術創新者提供生命科學試劑和服務的全球供應商 Maravai LifeSciences, Inc. 以 2.4 億美元的價格收購了專注於製造超純核甘酸的公司 Mychem, LLC。以 100 萬美元的價格收購了該公司。 此次收購擴大了 Maravai 的產品組合，為快速增長的 mRNA 治療和疫苗應用市場提供戰略投入。

市場參與者增加對基於 m-RNA 的 m-RNA 合成技術的投資以擴大其產品組合，預計將在預測期內推動市場增長。. 例如，2021年12月，金融公司Direxion宣布推出Direxion mRNA ETF，這是一隻專注於信使RNA技術應用和開發的新型交易所交易基金（ETF）。 該基金的目的是投資於正在開發和應用 mRNA 技術的公司。

這項研究的主要特點

• 本報告詳細分析了全球 m-RNA 合成服務市場，提出了以 2022 年為基準年的預測期 (2023-2030) 的市場規模（美國）和復合年增長率 (CAGR%)。）發布。
• 它闡明了各個細分市場的潛在收入機會，並概述了該市場具有吸引力的投資建議矩陣。
• 它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
• 根據公司亮點、產品組合、主要亮點、財務業績和戰略等參數，對全球 m-RNA 合成服務市場的主要參與者進行介紹。 本研究涵蓋的主要公司包括 Maravai LifeSciences、Azenta US, Inc.、Creative Biolabs、Becton、Dickinson And Company、Creative Biogene、Kaneka Corporation、Danaher、eTheRNA、Biomay AG、ApexBio Technology、RiboPro、F. Hoffmann -La Roche Ltd 、System Biosciences, LLC.、Aurigene Pharmaceutical Services Ltd.、OZ Biosciences、Aldevron 和 GenScript 包含
• 。
• 這份報告中的見解將使企業營銷人員和高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 《全球 m-RNA 合成服務市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球 m-RNA 合成服務市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫

第二章市場概況

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場概況：按應用分類
  • 市場概況：按操作規模
  • 市場概況：按最終用戶分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場吸引力分析
  • 市場機會
  • 產品發布
  • 合併/收購/聯合研究
  • 監管準則和合規性
  • 主要發展
  • 害蟲分析
  • 技術概況
  • 服務成本分析

第 4 章 m-RNA 合成服務的全球市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 對經濟的影響
• COVID-19 流行病學
• 對供需的影響

第 5 章 m-RNA 合成服務的全球市場：按應用，2017-2030

• 治療開發
• 疫苗製造
• 藥物發現
• 其他

第 6 章 2017-2030 年全球 m-RNA 合成服務市場，按運營規模分列

• 研究
• 商業

第 7 章最終用戶的 m-RNA 合成服務全球市場，2017-2030 年（百萬美元

• 生物製藥公司
• 合同研究組織 (CRO)
• 其他

第 8 章 2017-2030 年按地區分列的全球 m-RNA 合成服務市場

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第9章競爭格局

• Maravai LifeSciences
• Azenta US, Inc.
• Creative Biolabs
• Becton, Dickinson And Company
• Creative Biogene
• Kaneka Corporation
• Danaher
• eTheRNA
• Biomay AG
• ApexBio Technology
• RiboPro
• F. Hoffmann-La Roche Ltd
• System Biosciences, LLC.
• Aurigene Pharmaceutical Services Ltd.
• OZ Biosciences
• Aldevron
• GenScript

第 10 章

• 調查方法
• 關於出版商

Messenger RNA (mRNA) synthesis, using DNA as the template, is called transcription. The mRNA carries the genetic information from the chromosomes' DNA in the nucleus to the surface of the cytosol. mRNA is a flexible tool that is utilized for gene editing, cell therapy, vaccinations, and therapeutic protein replacement, among other . The ability to introduce any protein via mRNA enables the cellular production of gene editing tools or antigens.

mRNA is a single-stranded RNA molecule that is complementary to one of a gene's DNA strands. Synthetic mRNAs are used to investigate protein-mediated mRNA recognition, mRNA export and translation, and mutation effects on protein-coding genes. Recently, mRNA-based medicines have been developed for the treatment of various diseases including respiratory, cardiac, metabolic and autoimmune diseases, as well as cancer, cancer immunotherapy, and preventive vaccinations.

Market Dynamics

Increasing number of acquisitions between market players is expected to drive the market growth over the forecast period. For instance, in January 2022, Maravai LifeSciences, Inc., a global provider of life science reagents and services to researchers and biotech innovators, announced that it has acquired MyChem, LLC, company focused on making ultra-pure nucleotides, for US$ 240 million. This acquisition will expand Maravai's product offering of strategic inputs in the rapidly growing markets for mRNA therapeutics and vaccine applications.

Increasing investments for m-RNA based technologies for m-RNA synthesis by the key players in the market in order to expand their product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2021, Direxion, a financial corporation, announced the launch of the Direxion mRNA ETF, a new exchange-traded fund (ETF) that focuses on the applications and developments of messenger RNA technology. This fund seeks to invest in firms that are developing and applying mRNA technology.

Key features of the study:

• This report provides in-depth analysis of the global m-RNA synthesis service market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global m-RNA synthesis service market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies. Key companies covered as a part of this study include Maravai LifeSciences, Azenta US, Inc., Creative Biolabs, Becton, Dickinson And Company, Creative Biogene, Kaneka Corporation, Danaher, eTheRNA, Biomay AG, ApexBio Technology, RiboPro, F. Hoffmann-La Roche Ltd, System Biosciences, LLC., Aurigene Pharmaceutical Services Ltd., OZ Biosciences, Aldevron and GenScript
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global m-RNA synthesis service market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global m-RNA synthesis service market

Detailed Segmentation:

• Global m-RNA Synthesis Service Market, By Application:
  • Therapeutic Development
  • Vaccine Production
  • Drug Discovery
  • Others
• Global m-RNA Synthesis Service Market, By Scale of Operation:
  • Research
  • Commercial
• Global m-RNA Synthesis Service Market By End User:
  • Biopharmaceutical Companies
  • Contract research organizations (CROs)
  • Others
• Global m-RNA Synthesis Service Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Maravai LifeSciences*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Azenta US, Inc.
  • Creative Biolabs
  • Becton, Dickinson And Company
  • Creative Biogene
  • Kaneka Corporation
  • Danaher
  • eTheRNA
  • Biomay AG
  • ApexBio Technology
  • RiboPro
  • F. Hoffmann-La Roche Ltd
  • System Biosciences, LLC.
  • Aurigene Pharmaceutical Services Ltd.
  • OZ Biosciences
  • Aldevron
  • GenScript

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Application
  • Market Snapshot, By Scale of Operation
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
  • Product Launches
  • Merger, Acquisition, Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • Service Cost Analysis

4. Global m-RNA Synthesis Service Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global m-RNA Synthesis Service Market, By Application, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Therapeutic Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Vaccine Production
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global m-RNA Synthesis Service Market, By Scale of Operation, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017-2030
  • Segment Trends
• Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Commercial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global m-RNA Synthesis Service Market, By End User, 2017 - 2030, (US$ Million

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global m-RNA Synthesis Service Market, By Region, 2017-2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Maravai LifeSciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Azenta US, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Creative Biolabs
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Becton, Dickinson And Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Creative Biogene
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Kaneka Corporation
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Danaher
  • Company Highlights
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• eTheRNA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biomay AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ApexBio Technology
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• RiboPro
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• F. Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• System Biosciences, LLC.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Aurigene Pharmaceutical Services Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• OZ Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Aldevron
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GenScript
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us